209 related articles for article (PubMed ID: 17549482)
1. Pro-inflammatory cellular immune response in Behçet's disease.
Kulaber A; Tugal-Tutkun I; Yentür SP; Akman-Demir G; Kaneko F; Gül A; Saruhan-Direskeneli G
Rheumatol Int; 2007 Oct; 27(12):1113-8. PubMed ID: 17549482
[TBL] [Abstract][Full Text] [Related]
2. Elevated levels of interleukin-27 and effect on production of interferon-γ and interleukin-17 in patients with Behçet's disease.
Shen H; Xia LP; Lu J
Scand J Rheumatol; 2013; 42(1):48-51. PubMed ID: 23101722
[TBL] [Abstract][Full Text] [Related]
3. Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet's Disease.
Deniz R; Tulunay-Virlan A; Ture Ozdemir F; Unal AU; Ozen G; Alibaz-Oner F; Aydin-Tatli I; Mumcu G; Ergun T; Direskeneli H
Immunol Invest; 2017 Jul; 46(5):518-525. PubMed ID: 28414558
[TBL] [Abstract][Full Text] [Related]
4. Immune responses to interphotoreceptor retinoid-binding protein and S-antigen in Behcet's patients with uveitis.
Takeuchi M; Usui Y; Okunuki Y; Zhang L; Ma J; Yamakawa N; Hattori T; Kezuka T; Sakai J; Goto H
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3067-75. PubMed ID: 20089879
[TBL] [Abstract][Full Text] [Related]
5. Anti-MHC autoimmunity in Behçet's disease: T cell responses to an HLA-B-derived peptide cross-reactive with retinal-S antigen in patients with uveitis.
Kurhan-Yavuz S; Direskeneli H; Bozkurt N; Ozyazgan Y; Bavbek T; Kazokoglu H; Eksioglu-Demiralp E; Wildner G; Diedrichs-Möhring M; Akoglu T
Clin Exp Immunol; 2000 Apr; 120(1):162-6. PubMed ID: 10759778
[TBL] [Abstract][Full Text] [Related]
6. [Influence of steroid hormones on the production of two inflammatory markers, IL-12 and nitric oxide, in Behçet's disease].
Ahmedi ML; Belguendouz H; Messaoudene D; Mesbah-Amroun H; Terahi M; Lahlou-Boukoffa OS; Touil-Boukoffa C
J Fr Ophtalmol; 2016 Apr; 39(4):333-40. PubMed ID: 27021132
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cells dominate a Th-1 polarized response in Behçet's disease patients with uveitis.
Kucuksezer UC; Aktas-Cetin E; Bilgic-Gazioglu S; Tugal-Tutkun I; Gül A; Deniz G
Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S24-9. PubMed ID: 25937098
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte proliferation induced by high-affinity peptides for HLA-B*51:01 in Behçet's uveitis.
Kaburaki T; Nakahara H; Tanaka R; Okinaga K; Kawashima H; Hamasaki Y; Rungrotmongkol T; Hannongbua S; Noguchi H; Aihara M; Takeuchi F
PLoS One; 2019; 14(9):e0222384. PubMed ID: 31513650
[TBL] [Abstract][Full Text] [Related]
9. Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern.
Raziuddin S; al-Dalaan A; Bahabri S; Siraj AK; al-Sedairy S
J Rheumatol; 1998 Feb; 25(2):329-33. PubMed ID: 9489829
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-28A promotes IFN-γ production by peripheral blood mononuclear cells from patients with Behçet's disease.
Li B; Xie C; Lin X; Su SB
Cell Immunol; 2014 Jul; 290(1):116-9. PubMed ID: 24973639
[TBL] [Abstract][Full Text] [Related]
11. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
Hamzaoui K; Kaabachi W; Fazaa B; Zakraoui L; Mili-Boussen I; Haj-Sassi F
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Th Cell-related Cytokine Production in Behçet Disease Patients with Uveitis Before and After Infliximab Treatment.
Takeuchi M; Karasawa Y; Harimoto K; Tanaka A; Shibata M; Sato T; Caspi RR; Ito M
Ocul Immunol Inflamm; 2017 Feb; 25(1):52-61. PubMed ID: 27070371
[TBL] [Abstract][Full Text] [Related]
13. Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease.
Lucherini OM; Lopalco G; Cantarini L; Emmi G; Lopalco A; Venerito V; Vitale A; Iannone F
Immunol Lett; 2018 Sep; 201():38-44. PubMed ID: 30385329
[TBL] [Abstract][Full Text] [Related]
14. Behçet's disease patients present high levels of deglycosylated anti-lipoteichoic acid IgG and high IL-8 production after lipoteichoic acid stimulation.
Cuchacovich M; Merino G; Yamamoto JH; Villarroel F; Saavedra T; Jofre S; Gatica H; Velasquez V; Pizzo SV; Gonzalez-Gronow M
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S27-34. PubMed ID: 16273761
[TBL] [Abstract][Full Text] [Related]
15. Cytokine production of peripheral blood mononuclear cells stimulated with Streptococcus sanguis antigen in patients with Behçet's disease.
Lee KH; Kim HS; Kaneko F; Bang D
Adv Exp Med Biol; 2003; 528():255-60. PubMed ID: 12918702
[No Abstract] [Full Text] [Related]
16. Behçet's disease heterogeneity: cytokine production and oxidative burst of phagocytes are altered in patients with severe manifestations.
Perazzio SF; Soeiro-Pereira PV; de Souza AW; Condino-Neto A; Andrade LE
Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S85-95. PubMed ID: 26394190
[TBL] [Abstract][Full Text] [Related]
17. Anti-fibrotic characteristics of Vγ9+ γδ T cells in systemic sclerosis.
Markovits N; Bendersky A; Loebstein R; Brusel M; Kessler E; Bank I
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):23-29. PubMed ID: 26886502
[TBL] [Abstract][Full Text] [Related]
18. Expression and function of inducible costimulator on peripheral blood CD4+ T cells in Behçet's patients with uveitis: a new activity marker?
Usui Y; Takeuchi M; Yamakawa N; Takeuchi A; Kezuka T; Ma J; Matsuda R; Okunuki Y; Akiba H; Goto H
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5099-104. PubMed ID: 20445113
[TBL] [Abstract][Full Text] [Related]
19. Discrepancies of NKT cells expression in peripheral blood and in cerebrospinal fluid from Behçet's disease.
Hamzaoui K; Kamoun M; Houman H; Hentati F; Hamza M; Ayed K; Hamzaoui A
J Neuroimmunol; 2006 Jun; 175(1-2):160-8. PubMed ID: 16624421
[TBL] [Abstract][Full Text] [Related]
20. Intracellular cytokine patterns in Behçet's disease in comparison to ankylosing spondylitis--influence of treatment with interferon-alpha2a.
Amberger M; Groll S; Günaydin I; Deuter C; Vonthein R; Kötter I
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S52-7. PubMed ID: 17949552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
